Advancing global health
Expanding access to care around the world is at the heart of what we do and is exemplified by our team members’ dedication to our purpose. It takes a targeted approach to create healthier futures, and we accomplish that through both our business and philanthropic strategies to impact as many lives as possible. Through the efforts of our health equity working group, we are weaving equity considerations throughout our business. Whether it’s through an innovative solution or working closely with our partners, we carry out our purpose every day as we work in service of our customers, their patients, and our shared communities.
Facilitating innovation and collaboration
Cencora Healthier Futures Grant Program
Leading in times of health challenges
Cencora’s purpose drives us to action during supply disruptions. We collaborate across the supply chain and work with our suppliers, industry groups, nonprofits, government agencies, and our customers to advocate for patients. We also offer programs, like Sure Supply to support health systems’ access to high-risk or sensitive items. In urgent situations, our Customer Care and Replenishment Operations team members help facilitate patient access in shortage situations in various ways, including working with suppliers for reserved inventory or helping find other pharmacies that may have the medication on hand.
We continued to support COVID-19 vaccination efforts, including serving as a network administrator for the Federal Retail Pharmacy Program to ensure our Good Neighbor Pharmacy independent pharmacy customers received access to vaccines. To date, Cencora has allocated more than 8 million COVD-19 vaccines to independent pharmacies participating in the Federal Retail Pharmacy Program across the country. Approximately 50% of our pharmacies participating in the Federal Retail Pharmacy Program were in areas with high to moderate social vulnerability, as defined by the Centers for Disease Control and Prevention (CDC). We participated in this program until its end in FY23. In addition, we are distributing COVID-19 vaccines to our customers across the United States as vaccine distribution moved from a centralized, government-managed process to a traditional distribution model in September.
As a healthcare leader, we are continuously focused on what we may face next as a global population, such as the growing public health issue of antimicrobial resistance (AMR). The Cencora Impact Foundation contributed to the CDC Foundation’s AMR Fund to bring together partners and make meaningful progress in addressing AMR, including improving access to vaccines, therapeutics, and diagnostics for better prevention, treatment, and detection.
In FY23, the Cencora Impact Foundation donated a grant that will support an in-person roundtable of global subject matter experts, policy makers, and industry partners on AMR. This will serve as a catalyst for the creation of a new annual survey that will support global data collection on current public awareness, understanding, and attitudes of AMR and antibiotic and antifungal use. The data from this survey will help accelerate progress towards achieving the goals outlined in WHO’s Global Action Plan on Antimicrobial Resistance and the U.S. National Action Plan to Combat Antibiotic-Resistant Bacteria. We continued to support World AMR Awareness Week, through activities in Alphega pharmacies to drive greater public awareness of the risks of AMR and promote the role of pharmacy stewardship.
We also continue to advocate for vaccine equity across the world. In 2022, the Cencora Impact Foundation made an initial grant to the United Nations Foundation’s Shot@Life campaign to protect marginalized communities from devastating vaccine-preventable diseases. In 2023, the Foundation increased its support to protect the health of refugees and internally displaced people globally, and to vaccinate approximately 400,000 children around the world against polio.
Our stories of purpose
Across the enterprise, our team members collaborate with each other and our partners to advance global health and save lives. Here are just a few of our stories from FY23 that show how we lived our purpose and created meaningful impact.